T. Prazuck, J. E. Malkin, L. Belec, S. Chamaret, C. S le, A. Alcais, C

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Outbreak of campylobacter food-poisoning in Northern Ireland
Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following.
Outbreak of campylobacter food-poisoning in Northern Ireland
I.J. Schalk  Clinical Microbiology and Infection 
Salvage therapy for multidrug-resistant tuberculosis
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Atypical respiratory pathogens
Virological tools to diagnose and monitor hepatitis C virus infection
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
Hydatid disease Clinical Microbiology and Infection
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
Inga Odenholt, Elisabeth Löwdin, Otto Cars 
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Training for the infectious diseases speciality in Norway
Cephalosporins: a pharmacological update
Retrospective study of CMV retinitis in patients with AIDS
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
Salvage therapy for multidrug-resistant tuberculosis
Sepsis and neutropenia induced by clozapine
Gastrointestinal and respiratory Mycobacterium avium colonization and development of disseminated infection in HIV-positive patients  Giampietro Nardi,
Uncommon opportunistic fungi: new nosocomial threats
Metagenomics and probiotics
Anders Österlund, Lars Engstrand  Clinical Microbiology and Infection 
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
A case of pleurisy associated with antibodies to Rickettsia conorii
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
Pathogenesis of catheter-related infections: lessons for new designs
Antibacterial drug discovery in the 21st century
Community-acquired pneumonia: epidemiologic and clinical consideration
Training in infectious diseases and tropical medicine in Britain
Andrew M. Middleton, Maureen V. Chadwick, Harold Gaya 
Clinical infection services—the Leiden experience
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Statin use and clinical outcomes among pneumonia patients
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
J.M. García-Lechuz, M. Sánchez-Conde, L. Muñoz, C. Benito 
Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis  José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.
Overview of cefixime use in community-acquired infections
Tuberculosis in HIV-infected patients: a comprehensive review
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
High prevalence of GB virus C/hepatitis G virus infection in different risk groups of HIV- infected patients  P. Clevenbergh, J. Durant, P. Halfon, A.
Carratalà J.   Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip  M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,
New patterns of HIV-1 resistance during HAART
Overall trends in CD4 counts and plasma viremia in an urban clinic since the introduction of highly active antiretroviral therapies  J.C. Martín, V Soriano,
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Abstracts Clinical Microbiology and Infection
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

‘Brown sugar’ heroin intoxication and improvement of surrogate immunologic markers in HIV infection  T. Prazuck, J.E. Malkin, L. Belec, S. Chamaret, C. Semaille, A. Alcais, C. Lafaix  Clinical Microbiology and Infection  Volume 5, Issue 5, Pages 244-252 (May 1999) DOI: 10.1111/j.1469-0691.1999.tb00136.x Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Variation of CD4 T-cell count and HIV viral load according to intoxication period (IP) and withdrawal period (WP) in four different HIV positive IV drug users. Clinical Microbiology and Infection 1999 5, 244-252DOI: (10.1111/j.1469-0691.1999.tb00136.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Comparison of apoptosis of lymphocytes from drug-using HIV-infected persons cultured in medium or stimulated for 24 h with ionomycine or anti-CD3 monoclonal antibody (Iot3)) during intoxication and withdrawal periods. Clinical Microbiology and Infection 1999 5, 244-252DOI: (10.1111/j.1469-0691.1999.tb00136.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 Survival curves of HIV-positive active drug users and HIV-positive former drug users over a 5-year period. Clinical Microbiology and Infection 1999 5, 244-252DOI: (10.1111/j.1469-0691.1999.tb00136.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions